When guest writer Antonio Perez turned to social media to learn about MS, he saw a need to help other young people navigate ...

Hannah Campbell has had symptoms of MS since she was 8, and feels like the oftentimes invisible illness has affected all ...

A Phase 1 trial testing TG Therapeutics' CAR T-cell therapy azer-cel in progressive forms of MS is now recruiting across eight U.S. sites.

As columnist Ahna Crum marveled at the feats of Olympic medalists, she decided to grab a pair of ice skates and test her own ...

A second clinical trial testing fenebrutinib for MS has met its main goal, once again beating approved Aubagio in reducing ...

Scientists are embarking on a massive new research project to identify early warning signs of more than 25 diseases, including MS ...

Ocrevus (ocrelizumab) and Tysabri (natalizumab) appear equally effective at controlling relapses and MS progression, a study finds.

Donald Kushner says living with MS has made him the gravitational center of his family, and the person in the middle in group ...

Researchers mapped myelin-making cells in mice, showing some brain regions recover better after myelin damage.

Foralumab reduced microglial activity in people with nonactive SPMS, and this was linked to reductions in proinflammatory ...

Nin Sambhi shares what it's like to be on a journey of motherhood when a relapsing-remitting MS diagnosis happens, seemingly out of nowhere.

Merck and Mayo Clinic are partnering to use AI technology and large-scale clinical data to speed drug development in MS and other conditions.